Document:

Exhibit

[FOR USE FOR EXECUTIVE OUTSIDE OF U.S.]
INC RESEARCH HOLDINGS, INC. 
2014 Equity Incentive Plan
Performance Restricted Stock Unit Award Agreement for Non-U.S. Participants
This Performance Restricted Stock  Unit  Award Agreement for Non-U.S. Participants (this “Agreement”) including any special terms and conditions for the Participant’s country set  forth in Appendix B, attached hereto  (the Performance  Restricted  Stock  Unit  Agreement and Appendix  A and B, together, the “Agreement”) is made by and between INC Research Holdings, Inc., a Delaware corporation (the “Company”), and Participant Name (the “Participant”), effective as of Grant Date (the “Date of Grant”). 
RECITALS
WHEREAS, the Company has adopted the INC Research Holdings, Inc. 2014 Equity Incentive Plan (as the same may be amended and/or  amended and restated from time to time, the “Plan”), which  Plan  is  incorporated  herein  by reference and made a part of this Agreement,  and  capitalized  terms  not otherwise defined  in  this  Agreement  will have the meanings ascribed to those terms in the Plan; and
WHEREAS, the Committee  has authorized  and approved the grant of an Award to the Participant of  Performance Restricted Stock  Units payable  in shares  of Common Stock (the “Shares”), subject to the terms and conditions set forth in the Plan and this Agreement.  
NOW THEREFORE, in consideration of the premises and mutual covenants set forth in this Agreement, the parties agree as follows:
		
	1.
	Grant  of  Performance  Restricted  Stock  Units.   The Company  has granted to  the Participant,  effective  as  of the Date of  Grant, Number  of PRSUs Granted (“Total Award”) Performance Restricted Stock Units, on the terms and conditions set forth in the Plan and this Agreement, subject to adjustment as set forth in the Plan (the “PRSUs”).  

		
	2.
	Vesting Eligibility of PRSUs.  Subject to  the  terms  and conditions set forth in the Plan and this Agreement, the PRSUs will be eligible for vesting as follows:

		
	(a)
	General.   Except  as otherwise  provided  in Section  2(b),  the  PRSUs will be eligible for vesting based on the attainment  of certain Performance Goals during the  Performance  Periods as  set  forth  on  Appendix A.  The Committee will, promptly after the filing of the Company’s Form 10-K (or other report publicly furnished to the Securities and Exchange Commission (“SEC”)) for each of the Performance Periods, review the applicable financial data as reported in the Form 10-K (or such other report referenced above) and certify in writing whether and to what extent the Performance Goals for each Performance Period set forth in Appendix A have  been attained,  and  what PRSUs  are eligible for vesting as a result of  such  performance, in  accordance with Section 10  of  the Plan.  In no event  will  determination  of  achievement  of the Performance  Goals  occur  later

1 

than two and one-half (2 1⁄2) months  following  the end of the last Performance Period. Only to the extent the Performance Goals are achieved, as certified by the Committee, will the PRSUs be eligible for vesting and settlement as described in Section 3 below.
		
	(b)
	Effect  of  Change  in  Control.  Any portion of the Total Award not previously forfeited will be  deemed  fully  vested  immediately upon the Participant’s termination of Service (i) by the Company without Cause (as defined in the Plan), or (ii) by Participant  for  Good Reason as described  below, in  either case at the time of, or within twelve (12)  months immediately following, the consummation of a Change in Control occurring after the Date of Grant (either of such events of termination within such period, a “CIC Termination”).

		
	(c)
	Good  Reason  Defined.  As used  in  this Agreement, “Good Reason” shall mean the occurrence, without Participant’s  express  written  consent, of any of the following events: (i) a material reduction in Participant’s base  salary  or Target Bonus percentage under the INC Research, LLC Management Incentive Plan, if applicable; (ii) a material adverse change to Participant’s authority, job duties or responsibilities  as  compared  to  Participant’s  authority,  job  duties  or responsibilities  immediately  prior  to the Change in Control; (iii) a requirement that Participant relocate to a principal place of employment more than fifty (50) miles from the Company’s offices at 3201 Beechleaf Court, in Raleigh, North Carolina or Participant’s assigned principal office location with any Subsidiary as of immediately  prior  to  the  occurrence  of  the Change in Control; or (iv) if Participant has an effective employment agreement, service agreement, or other similar agreement with the Company or any Subsidiary, a material breach of such agreement, provided,  that,  any  event described in clauses (i), (ii), (iii) and (iv) above shall constitute Good Reason only if the Participant provides the Company with  written  notice  of  the basis for  the  Participant’s  Good  Reason  within  forty-five (45) days of the initial actions or inactions of the Company or any Subsidiary giving  rise  to such Good Reason and the Company or applicable Subsidiary has not cured the identified actions or inactions within thirty (30) days of such notice, and  provided  further that Participant  terminates his or her Service within thirty (30) days following the Company or applicable Subsidiary’s failure to cure within the thirty (30) day cure period.

		
	3.
	Settlement of PRSUs.

		
	(a)
	Settlement in Stock.  PRSUs  eligible for vesting as described in Section 2 above will be settled by delivering to Participant, by one of  the  methods set forth  in Section  3(b)  below,  a number of Shares  equal to the number of such vesting-eligible PRSUs on the Vesting Date (as hereafter defined).  For purposes of this Agreement, the “Vesting Date” will be the earlier of (x) the date on which the Committee approves the achievement of the Performance Goals after the filing of the Form 10-K for the year ending December 31, 2018 (or such other report referenced in Section 2(a) above), provided that the Participant must remain in 

2 

Service through such date, or (y) the date on which a CIC Termination occurs, in each case subject to the provisions of Section 7 of this Agreement.  
		
	(b)
	Book­Entry Registration of  the  Shares; Delivery of Shares.  As soon as practical after   the  Vesting  Date  but  in  no  event  later  than  two  and  one-half  (21⁄2)  months  following  the  end  of  the  calendar  year  in  which  the  Vesting Date occurs,  the  Company  will,  at  its   election,   either: (i)  issue  a  certificate  representing the Shares payable pursuant to this Agreement; or (ii) not issue any certificate  representing  the  Shares  payable  pursuant  to  this  Agreement and instead  document  the  Participant’s  interest  in  the Shares by registering such Shares with the Company’s transfer agent (or another custodian selected by the Company)  in  book­entry  form in the  Participant’s name.  In any case, subject to the  maximum   payment  period  set   forth  above  in  this  Section  3(b),  the  Company  may  provide  a reasonable  delay in  the  issuance or delivery of the Shares to  address  Tax-­Related Items,  withholding,  and  other administrative matters.  Neither the Company nor the Committee will be liable to the Participant or any other Person  for  damages  relating  to any delays in issuing the Shares or any mistakes or errors in the issuance of the Shares.

		
	(c)
	Shareholder Rights. The Participant will not have any rights of a stockholder with respect to the Shares subject to the PRSUs, including voting and dividend rights, unless and until the Shares are delivered as described in Section 3(b) above.

		
	(d)
	Responsibility  for  Taxes.   The  Participant  acknowledges  that,  regardless  of  any action  taken  by  the Company or,  if different,  the  Subsidiary  employing or retaining  the  Participant  (the “Employer”),  the  ultimate  liability for all Tax-Related Items is and remains the Participant’s responsibility and may exceed the amount  actually  withheld  by  the Company or the Employer.  The Participant further acknowledges that the Company and/or the Employer (1) make no representations  or undertakings regarding the treatment of any Tax-Related Items in  connection  with any aspect of  the PRSUs,  including, but not limited to, the grant or vesting of the PRSUs, the delivery of Shares following the Vesting Date, the subsequent sale of Shares acquired pursuant to such vesting/delivery and the receipt  of any dividends  and/or  dividend equivalents; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the PRSUs to reduce or eliminate the Participant’s liability for Tax-Related Items or achieve  any  particular  tax result.  Further,  if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company  and/or  the  Employer (or former Employer,  as  applicable) may be required  to  withhold  or account  for  Tax-Related  Items  in more than one jurisdiction.

		
	(e)
	Withholding  Requirements.   Prior to  any  relevant  taxable or tax withholding event, as applicable, the Participant agrees to make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax-Related Items.  In  this  regard, the  Participant authorizes the Company and/or the Employer, or their  respective  agents, at  the Company’s and/or the Employer’s discretion, to 

3 

satisfy  the  obligations with  regard  to  all Tax-Related  Items  by  one  or  a combination  of  the  following: (1) withholding from the Participant’s wages or other cash compensation paid to the Participant by the Company and/or the Employer;  (2) withholding from proceeds of the sale of Shares acquired upon vesting/settlement of the PRSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on the Participant’s behalf pursuant to this  authorization); or (3)  withholding  in  Shares to be issued upon settlement of the PRSUs; provided, however that if the Participant is a Section 16 officer of the Company  under the  Exchange Act  and as  approved by the Board of Directors, then the Committee (as constituted in accordance with Rule 16b-3 under the Exchange Act) shall establish the method of withholding from alternatives (1)-(3) herein  and,  if  the Committee does not exercise its discretion prior to the Tax-Related Items withholding event, then the Participant shall be entitled to elect the method of withholding from the alternatives above.
Depending on the withholding method, the Company may withhold or account for Tax-Related  Items  by  considering  applicable  minimum statutory withholding rates or other  applicable  withholding rates, including maximum applicable rates, in which case the Participant will receive a refund of any over-withheld amount in cash  and  will  have  no  entitlement to the Common Stock equivalent.  If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant is deemed to have been issued the full number of Shares subject to the vested PRSUs, notwithstanding that a number of the Shares is held back solely for the purpose of paying the Tax-Related Items.
Finally, the Participant agrees to pay to the Company or the Employer, including through  withholding  from  the  Participant’s wages or other cash compensation paid to the Participant by the Company and/or the Employer, any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of the Participant’s participation in the Plan that cannot be satisfied by the means previously described.  The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if the Participant fails to comply with  the  Participant’s  obligations  in connection with the Tax-Related Items.
		
	4.
	Forfeiture.  Except as provided in Section 2(b) above relating to certain terminations of Service  occurring in  connection  with a Change in Control, all PRSUs (whether eligible for   vesting  or  not)  will  be  forfeited  immediately,   automatically   and  without  consideration  upon a termination of the Participant’s Service for any reason (whether or not  later  to  be  found  invalid  or  in breach  of  employment  laws  in  the jurisdiction where  the  Participant  is  employed  or  the  terms  of  the Participant’s employment agreement,  if   any)  prior to the Vesting Date.  In addition, any PRSUs for a given Performance  Period which  are  not  eligible  for  vesting  after  determination of the attainment  of  the Performance  Goals  for  such  Performance  Period  will  be  forfeited as   of   the  date  of  certification  by  the  Committee  and  will  not  carry   over   to  subsequent Performance Periods.  Without limiting the generality of the foregoing, the 

4 

PRSUs and the Shares (and any resulting proceeds) will continue to be subject to Section 13 of the Plan.
		
	5.
	Adjustment to PRSUs.  In the event of any change with respect to the outstanding Shares contemplated by Section 4.5 of the Plan, the PRSUs may be adjusted in accordance with Section 4.5 of the Plan.

		
	6.
	Nature of Grant.  In accepting the PRSUs, the Participant acknowledges, understands and agrees that:

		
	(a)
	the Plan  is  established  voluntarily by the Company, it is discretionary in nature and  it  may  be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan;

		
	(b)
	the  grant of the PRSUs is voluntary and occasional and does not create any contractual or other right to receive future grants of PRSUs, or benefits in lieu of PRSUs, even if PRSUs have been granted in the past; 

		
	(c)
	all  decisions  with  respect to future PRSUs or other grants, if any, will be at the sole discretion of the Company; 

		
	(d)
	the  PRSUs  and the Participant’s participation in the Plan shall not be interpreted as forming  an  employment  or  services  contract with the Company or any Subsidiary; 

		
	(e)
	the Participant is voluntarily participating in the Plan; 

		
	(f)
	the PRSUs and the Shares subject to the PRSUs are not intended to replace any pension rights or compensation; 

		
	(g)
	the PRSUs  and  the  Shares  subject to the PRSUs, and the income and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, holiday pay, long-service awards, pension or retirement or welfare benefits or similar payments; 

		
	(h)
	unless otherwise  agreed with the Company, the PRSUs and the Shares subject to the  PRSUs,  and the income  and value of same, are not granted as consideration for,  or in connection with,  the  service that the  Participant  may  provide  as a director of a Subsidiary;

		
	(i)
	the future  value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty; 

		
	(j)
	no claim or entitlement to compensation or damages shall arise from forfeiture of the  PRSUs  resulting from the termination of the Participant’s Service (for any reason  whatsoever whether or not later found to be invalid or in breach of employment  laws in  the  jurisdiction where  the  Participant is employed or the 

5 

terms of the Participant’s employment agreement, if any), and in consideration of the grant of the PRSUs to which the Participant is otherwise not entitled, the Participant irrevocably agrees never to institute any claim against the Company or any of  its  Subsidiaries, waives his or her ability, if any, to bring any such claim, and releases the Company and its Subsidiaries from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, the Participant shall be deemed irrevocably to have agreed not to pursue such claim and agrees to execute any and all documents necessary to request dismissal or withdrawal of such claim;
		
	(k)
	neither the Company nor any Subsidiary shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the PRSUs or of any amounts due to the Participant pursuant to the settlement of the PRSUs or the subsequent sale of any Shares acquired upon settlement.

		
	7.
	No Advice Regarding Grant.  The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant’s participation in the Plan, or the Participant’s acquisition or sale of the underlying Shares.  The Participant is hereby advised to consult with the Participant’s own personal tax, legal and financial  advisors regarding the Participant’s participation in the Plan before taking any action related to the Plan.

		
	8.
	Data Privacy.  The Participant hereby explicitly and unambiguously consents to the collection,  use and transfer, in electronic or other form, of the Participant’s personal data  as  described in  this  Agreement  and  any other PRSU grant materials by and among,  as  applicable,  the  Employer,  the  Company  and  its  Subsidiaries for the exclusive purpose of implementing, administering and managing the Participant’s participation in the Plan.

The Participant understands that the Company and the Employer may hold certain personal  information  about  the Participant,  including, but not limited to, the Participant’s  name,  home address and  telephone  number,  date  of  birth,  social  insurance number or other identification  number,  salary,  nationality,  job title, any shares of stock or directorships held in the Company, details of all PRSUs or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor (“Data”), for the exclusive purpose of implementing, administering and managing the Plan. 
The  Participant  understands  that  Data will  be  transferred to Fidelity Stock Plan Services, LLC or any other broker selected by the Company, or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan.  The Participant  understands  that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different  data  privacy laws and protections than the Participant’s country.  The Participant understands that the Participant may request a list with the names and 

6 

addresses of any potential recipients of the Data by contacting the Participant’s local human  resources  representative.  The  Participant authorizes the Company, Fidelity Stock Plan Services, LLC or any other broker selected by the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing,  administering  and managing  the Plan to receive,  possess, use, retain and  transfer   the  Data,  in  electronic or  other  form, for  the  sole  purpose  of  implementing, administering and managing the Participant’s participation in the Plan.  The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the Participant’s participation in the Plan.  The Participant understands that the Participant may, at any time, view Data, request additional  information  about  the  storage  and  processing  of  Data,  require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Participant’s local human resources representative.  Further,  the Participant understands that the Participant is providing the consents herein on a purely voluntary basis. If  the Participant does not consent, or if  the Participant  later seeks  to  revoke the  Participant’s consent, the Participant’s Service  and  career with  the  Employer  will not be adversely affected; the only consequence of refusing or withdrawing the Participant’s consent is that the Company would  not  be able to  grant PRSUs  or other  equity awards to  the  Participant or administer  or maintain such awards.  Therefore, the Participant understands that refusing  or  withdrawing the Participant’s  consent may affect the Participant’s ability to  participate  in  the  Plan.  For  more  information  on the consequences of the Participant’s refusal to consent or withdrawal of consent, the Participant understands that  the  Participant  may  contact  the  Participant’s  local  human  resources representative.
		
	9.
	Language.   If  the Participant has received this Agreement or any other document related to  the  Plan  translated  into  a  language other than English and if the meaning of the translated version is different than the English version, the English version will control.

		
	10.
	Electronic Delivery and Acceptance.  The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and  agrees  to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

		
	11.
	Imposition of Other Requirements.  The Company reserves the right to impose any other requirements  on  the Participant’s  participation  in the Plan, on the PRSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Participant to sign any additional  agreements  or  undertakings that  may  be  necessary  to  accomplish  the foregoing.

		
	12.
	Appendix B.   Notwithstanding  any provisions in this Agreement,  the PRSUs shall be subject to  any  special  terms and conditions set forth in Appendix B for the Participant’s country.  Appendix B constitutes  part  of  this  Performance  Restricted  Stock Unit Agreement.

7 

		
	13.
	Insider Trading Restrictions/Market Abuse Laws.  The Participant acknowledges that, depending  on  his  or  her  country,  the Participant may be subject to insider trading restrictions and/or market abuse laws, which  may affect his or  her  ability to acquire  or sell Shares or rights to Shares (e.g., PRSUs) under the Plan during such times as the Participant is considered to have “inside information” regarding the Company (as defined by the laws in the Participant’s country).  Any restrictions under these laws or regulations are  separate  from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.  The Participant is responsible for ensuring compliance with any applicable restrictions and is advised to consult his or her personal legal advisor on this matter.

		
	14.
	Miscellaneous Provisions

		
	(a)
	Securities or Exchange Control Laws Requirements.  No Shares will be issued or transferred pursuant to this Agreement unless and until all then applicable requirements  imposed  by  federal and state securities and other securities or exchange  control laws, rules  and regulations  and  by  any regulatory agencies having jurisdiction, and by any exchanges upon which the Shares may be listed, have  been fully met.  As a condition precedent to the issuance of Shares pursuant to  this  Agreement,  the Company may  require  the  Participant  to  take  any reasonable action to meet those requirements.  The Committee may impose such conditions on any Shares issuable pursuant to this Agreement as it may deem advisable,  including, without limitation, restrictions under the Securities Act of 1933, as amended, under the requirements of any exchange upon which shares of the same class are then listed and under any blue sky or other securities laws applicable to those Shares.  

		
	(b)
	Non-­Transferability.   The PRSUs and the rights and privileges conferred thereby shall be  non-transferrable except as provided by Section 15.3 of the Plan.  Any  Shares delivered hereunder will be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the Plan or the rules, regulations  and other requirements of the Securities and Exchange Commission, any  stock  exchange  upon which such  shares are listed, any applicable federal, state or local laws and any agreement with, or policy of, the Company or the Committee to which the Participant is a party or subject, and the Committee may cause  orders  or  designations  to  be placed  upon  any  certificate(s) or other document(s) delivered to the Participant, or on the books and records of the Company’s transfer agent, to make appropriate reference to such restrictions.

		
	(c)
	No Right to  Continued Service.   Nothing in this Agreement or the Plan confers upon the Participant any right to continue in Service for any period of specific duration  or  interfere  with  or  otherwise  restrict in any way the rights of the Company (or any Subsidiary employing or retaining the Participant) or of the Participant,  which  rights  are hereby expressly reserved by each, to terminate his or her Service at any time and for any reason, with or without Cause.

8 

		
	(d)
	Notification.   Any  notification  required by the terms of this Agreement will be given by the Participant (i) in a writing addressed to the Company at its principal executive office and will be deemed effective upon actual receipt when delivered by  personal  delivery  or  by registered or certified mail, with postage and fees prepaid, or (ii) by electronic transmission to the Company’s e-mail address of the Company’s  General  Counsel  and will be deemed effective upon actual receipt.  Any notification required by the terms of this Agreement will be given by the Company (x)  in  a  writing addressed  to  the address that the Participant most recently provided to the Company and will be deemed effective upon personal delivery or within three (3) days of deposit with the United States Postal Service, by  registered  or certified mail, with postage and fees prepaid, or (y) by facsimile or electronic transmission to the Participant’s primary work fax number or e-mail address (as applicable) and will be deemed effective upon confirmation of receipt by the sender of such transmission.

		
	(e)
	Entire Agreement.  This Agreement and the Plan constitute the entire agreement between  the  parties  hereto with regard to the subject matter of this Agreement.  This Agreement and the Plan supersede any other agreements, representations or understandings  (whether  oral  or written  and  whether express or implied) that relate to the subject matter of this Agreement.

		
	(f)
	Waiver.   No  waiver of  any  breach  or condition  of  this  Agreement  by the Participant or any other Participant will be deemed to be a waiver of any other or subsequent breach or condition whether of like or different nature.

		
	(g)
	Successors and Assigns.  The  provisions of  this  Agreement  will inure  to  the  benefit of, and be binding upon, the Company and its successors and assigns and upon the Participant, the Participant’s executor, personal representative(s), distributees,  administrator,  permitted transferees, permitted assignees, beneficiaries,  and  legatee(s), as applicable, whether or not any such person will have become a party  to this Agreement and have agreed in writing to be joined herein and be bound by the terms hereof.

		
	(h)
	Severability.   The  provisions  of this Agreement  are  severable,  and  if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part,  then the remaining provisions will nevertheless be binding and enforceable.

		
	(i)
	Amendment.  Except as  otherwise provided in  the Plan, this Agreement will not be amended unless the amendment is agreed to in writing by both the Participant and the Company.

		
	(j)
	Choice of Law; Jurisdiction.  This Agreement and all claims, causes of action or proceedings (whether in contract, in tort, at law or otherwise) that may be based upon, arise  out  of  or  relate  to this Agreement will be governed by the internal laws of the State of Delaware, excluding any conflicts or choice-of-law rule or principle  that  might  otherwise  refer  construction  or interpretation of this 

9 

Agreement  to  the  substantive  law of another jurisdiction.  The Participant and each  party to this Agreement agrees that it will bring all claims, causes of action and  proceedings  (whether  in contract, in tort, at law or otherwise) that may be based  upon,  arise out of or be related to the Plan and this Agreement exclusively in the  Delaware  Court  of  Chancery or, in the event (but only in the event) that such court  does  not  have subject matter jurisdiction over such claim, cause of action  or  proceeding,  exclusively  in  the  United States District Court for the District of Delaware (the “Chosen Court”), and hereby (i) irrevocably submits to the exclusive jurisdiction of the Chosen Court, (ii) waives any objection to laying venue in any such proceeding in the Chosen Court, (iii) waives any objection that the Chosen Court is an inconvenient forum or does not have jurisdiction over any party and (iv) agrees that service of process upon such party in any such claim or cause  of  action  will  be  effective  if notice is given in accordance with this Agreement.
		
	(k)
	Signature  in  Counterparts.  This Agreement may  be  signed in counterparts, manually or electronically, each of which will be an original, with the same effect as if the signatures to each were upon the same instrument.

		
	(l)
	Acceptance.  The Participant  hereby acknowledges receipt of a copy of the Plan and this Agreement.  The Participant has read and understands the terms and provisions  of  the Plan and this  Agreement, and accepts the PRSUs subject to all of  the  terms  and conditions of the Plan and this Agreement.  In the event of a conflict between any term or provision contained in this Agreement and a term or provision  of  the  Plan, the applicable term and provision of the Plan will govern and prevail.

[Signature page follows.]

10 

IN WITNESS WHEREOF, the Company and the Participant have executed this Stock PRSUs Award Agreement as of the date first written above. 
INC RESEARCH HOLDINGS, INC.
By:                        
Name:    
Title:    

PARTICIPANT
[Electronic Signature]                 
______________________________        
Participant Signature                    
Name: [Participant Name]
Acceptance Date: [Acceptance Date]

Signature Page to Performance Restricted Stock Unit Award Agreement

APPENDIX A
PERFORMANCE GOALS FOR PRSU VESTING ELIGIBILITY
The  vesting  eligibility  of the PRSUs granted pursuant to the attached Performance Restricted Stock Unit Award Agreement will be determined by the Committee in accordance with the Plan and this Appendix A.
Performance Periods:  There will be three performance periods in which one-third of the Total Award  amount  granted  in  Section  1  above will be measured against the Performance Goals stated in the table below for each year.

	
				
	Performance
Period
	Performance Goal
	Dates
	Units Subject to the Performance Goal

	1
	2016 EPS
	January 1, 2016 to December 31, 2016
	One-third of Total  Award

	2
	2017 EPS
	January 1, 2017 to December 31, 2017
	One-third of Total  Award

	3
	2018 EPS
	January 1, 2018 to December 31, 2018
	One-third of Total  Award

Performance Goals:   PRSUs  will  be  eligible  for vesting based upon Adjusted Diluted Net Income Earnings per share (or EPS) for each of the three Performance Periods as reported in the Company’s   Form  10-K, or  in  such  other  report  publicly  filed with  the  SEC, for  each Performance Period based on the following schedules.
<financial targets>
No pro-rated  portion of the PRSUs for a given Performance Period will be eligible for vesting based on EPS levels between the stated amounts.

Appendix A – Performance Restricted Stock Unit Award Agreement

APPENDIX B
INC RESEARCH HOLDINGS, INC. 
2014 Equity Incentive Plan
Performance Restricted Stock Unit Award Agreement

Country-Specific Terms and Conditions

Capitalized  terms  used but not otherwise defined herein shall have the meaning given to such terms in the INC Research Holdings, Inc. 2014 Equity Incentive Plan (the “Plan”) and the Performance  Restricted  Stock Unit  Award  Agreement  for Non-U.S. Participants (the “Performance Restricted Stock Unit Agreement”).  This Appendix constitutes part of the Performance Restricted Stock Unit Agreement.
Terms and Conditions
This Appendix B  includes additional terms and conditions that govern the PRSUs granted to the Participant if the Participant  resides  and/or works in a country listed below.  If the Participant moves  to  another country  after receiving  the grant of the PRSUs, the Company will, in its discretion, determine the extent to which the terms and conditions herein will be applicable to the Participant.
Notifications
This Appendix B  also includes information regarding exchange controls and certain other issues of  which  the  Participant  should be aware with respect to the Participant’s participation in the Plan.  The information is based on the securities, exchange control and other laws in effect in the respective  countries  as  of January 2016.  Such  laws are often complex and change frequently.  As a result, the Company strongly recommends that the Participant not rely on the information in this  Appendix  B  as the only source  of  information  relating  to the  consequences  of  the  Participant’ s participation in the Plan because the information may be out of date at the time that the PRSUs vest or the Participant sells Shares acquired under the Plan.
In addition,  the  information contained herein is general in nature and may not apply to the Participant’ s particular situation and the Company is not in a position to assure the Participant of a particular result.  Accordingly, the Participant should seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to the Participant’s situation.
Finally, if the  Participant  is a  citizen or resident of a country other than the one in which he or she is currently residing and/or working (or if the Participant is considered as such for local law purposes), the information contained herein may not be applicable to the Participant in the same manner.

Appendix B – Performance Restricted Stock Unit Award Agreement

Appendix B-2

UNITED KINGDOM
Terms and Conditions
Responsibility for Taxes.  The following provisions supplement Section 3 of the Performance  Restricted Stock Unit Agreement:
If  payment or  withholding of the income tax due is not made within ninety (90) days of the end of  the  tax  year  in which  the  event   giving  rise to the liability occurs or such other period specified in Section 222(1)(c) of the U.K. Income Tax (Earnings and Pensions)  Act  2003  (the “Due Date”), the amount  of  any  uncollected income tax will constitute a loan owed by the Participant  to the Company or the Employer, effective on the Due Date.  The Participant agrees that the loan will bear interest at the then-current Official Rate of Her Majesty’s Revenue and Customs  (“HMRC”), it  will  be  immediately due and repayable,  and  the  Company  or the Employer may recover it at any time thereafter by any of the means referred to in the Plan or in Section 3 of the Performance Restricted Stock Unit Agreement.
Notwithstanding  the  foregoing,  if  the  Participant  is a director or  executive officer  of the Company  (within  the  meaning of Section  13(k)  of the Exchange Act), he or she will not be eligible for such a loan to cover the income tax due as described above.  In the event that the Participant is such a director or executive officer and the income tax is not collected from or paid by the Participant by the Due Date, the amount of any uncollected income tax may constitute a benefit  to  the  Participant on which additional income tax and national insurance contributions may be payable.  The Participant is  responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime.  The Participant is responsible for reimbursing the Company or the Employer (as applicable) for the value of any employee national insurance  contributions due on this additional benefit and acknowledges that the Company or the Employer may recover such amount from him or her by any of the means referred to in Plan or in Section 3 of the Performance Restricted Stock Unit Agreement.

Appendix B– Performance Restricted Stock Unit Award AgreementExhibit

Exhibit 10.1
EXECUTIVE EMPLOYMENT AGREEMENT
This Executive Employment Agreement (the “Agreement”), is entered into as of June 11, 2015 (the “Effective Date”), by and between Pacira Pharmaceuticals, Inc., a California corporation (the “Company”), and Scott Braunstein (the “Executive”).
RECITALS
WHEREAS, the Company wishes to employ the Executive, and the Executive desires to be employed by the Company, for such purpose and upon the terms and conditions hereinafter provided; and 
WHEREAS, the parties wish to establish the terms of the Executive’s future employment with the Company and set out fully their respective rights, obligations and duties.
AGREEMENT
In consideration of the promises and the terms and conditions set forth in this Agreement, the parties agree as follows:
1.    Title and Capacity.  The Company hereby agrees to continue to employ the Executive, and the Executive hereby accepts continued employment with the Company, under the terms set forth in this Agreement. The Executive will serve as the  Senior Vice President, Strategy and Corporate Development and shall perform such duties as are ordinary, customary and necessary in such role. The Executive will report directly to the President and CEO. The Executive shall devote his full business time, skill and attention to the performance of his duties on behalf of the Company. 
2.    Compensation and Benefits.
(a)    Salary.  The Company agrees to pay the Executive an annual base salary of Three Hundred Ninety-Five Thousand Dollars ($395,000.00) payable in accordance with Company’s customary payroll practice (the “Base Salary”). The Executive’s Base Salary shall be reviewed periodically by the Board of Directors of the Company (the “Board”); provided, however, that any such review will not necessarily result in an adjustment to the Executive’s Base Salary. Any change in the Executive’s Base Salary must be approved by the Board. 
(b)    Bonus.  The Executive is eligible to receive, in addition to the Base Salary and subject to the terms hereof and at the full discretion of the Board, a targeted incentive bonus of Forty percent (40%) of Base Salary (the “Targeted Incentive Bonus”). The Targeted Incentive Bonus shall be based on the Executive’s and the Company’s performance during the applicable fiscal year, as determined by the Board. The Targeted Incentive Bonus criteria or “goals” will be determined by agreement between the Board and the Executive at beginning of each fiscal year. The award of the Target Incentive Bonus may be in an amount either above or below the amount specified by the Board at the beginning of each fiscal year based on the ultimate performance assessed by the Board.
Targeted Incentive Bonuses shall be determined and approved by the Board in its sole discretion. 
All salary and bonuses shall be subject to all applicable withholdings and deductions. 
(c)    Stock Options.  Company will grant to the Executive a stock option (“Option”) to purchase an aggregate of Seventy Five Thousand (75,000) shares of the Company’s common stock, $0.001 par value per share (along with any subsequent grants, the “Option Shares”), pursuant to the Company’s Amended and Restated 2011 Stock Option/Stock Issuance (the “Plan”).  The exercise price, vesting schedule and other terms for the Option will be set forth in the notice of grant and option agreement for such Option and the Option is subject to accelerated vesting as set forth in Section 3 hereof. Additional equity incentives, if any, shall be determined by the Board (or a committee thereof) in its sole discretion. All share figures set forth herein shall be subject to adjustment for stock splits, stock dividends, stock combinations, recapitalizations and similar events.  
(d)    Benefits.  The Executive (and, where applicable, the Executive’s qualified dependents) will be eligible to participate in health insurance and other employee benefit plans and policies established by the Company for its executive team from time to time on substantially the same terms as are made available to other such employees of the Company generally. The Executive’s participation (and the participation of the Executive’s qualified dependents) in the Company’s benefit plans and policies will be subject to the terms of the applicable plan documents and the Company’s generally applied policies, and the Company in its sole discretion may from time to time adopt, modify, interpret or discontinue such plans or policies.  

(e)    Expenses.  The Company will reimburse the Executive for all reasonable and necessary expenses incurred by the Executive in connection with the Company’s business, in accordance with the applicable Company policy as may be amended from time to time.
(f)     Vacation and Holidays.  The Executive shall be eligible for thirty (30) days’ paid vacation/flexible time off per calendar year subject to the applicable terms and conditions of the Company’s vacation policy and applicable law.  
(g)    Termination of Benefits.  Except as set forth in Section 3 or as otherwise specified herein or in any other agreement between the Executive and the Company, if the Executive’s employment is terminated by the Company for any reason, with or without Cause (as defined below), or if the Executive resigns the Executive’s employment voluntarily, with or without Good Reason (as defined below), no compensation or other payments will be paid or provided to the Executive for periods following the date when such a termination of employment is effective, provided that any rights the Executive may have under the Company’s benefit plans shall be determined under the provisions of such plans. If the Executive’s employment terminates as a result of the Executive’s death or disability, no compensation or payments will be made to the Executive other than those to which the Executive may otherwise be entitled under the benefit plans of the Company.
3.    Compensation and Benefits Upon Termination of Employment. Upon termination of the Executive’s employment (such date of termination being referred to as the “Termination Date”), the Company will pay the Executive the compensation and benefits as described in this Section 3.
(a)    General Benefits Upon Termination.  The Company will pay the Executive on or about the Termination Date all salary and vacation/personal time off pay, if any, that has been earned or accrued through the Termination Date and that has not been previously paid.
(b)      Termination without “Cause” or for “Good Reason”.  In the event that the Company terminates the Executive’s employment without Cause (as defined below) or, in the event the Executive terminates his employment for Good Reason (as defined below), in each case, (i) the Executive shall be entitled to receive (A) continuing payments of the then effective Base Salary for a period of nine (9) months beginning on the Payment Commencement Date and payable in accordance with the Company’s payroll policies and (B) the benefits set forth in Section 3(e), and (ii) the Executive shall be entitled to acceleration of vesting of such number of Option Shares and time based restricted stock unit grants then held by Executive as would have vested in the nine (9) month period following the Termination Date had the Executive continued to be employed by the Company for such period, provided, however that in each case the receipt of such payments and benefits is expressly contingent upon the Executive’s execution and delivery of a severance and release of claims agreement drafted by and satisfactory to counsel for the Company (the “Release”) which Release must be executed and become effective within sixty (60) days following the Termination Date. The payments and benefits shall be paid or commence on the first payroll period following the date the Release becomes effective (the “Payment Commencement Date”).  Notwithstanding the foregoing, if the 60th day following the Termination Date occurs in the calendar year following the termination, then the Payment Commencement Date shall be no earlier than January 1st of such subsequent calendar year. The provision of payments and benefits pursuant to this Section shall be subject to the terms and conditions set forth on Exhibit A.
(c)    Termination without “Cause” or for “Good Reason” Prior to or Following a Change of Control.  In the event that the Company terminates the Executive’s employment without Cause (as defined below) or, in the event the Executive terminates his employment for Good Reason (as defined below), in each case, within thirty (30) days prior to, or twelve (12) months following, the consummation of a Change of Control, then (i) the Executive shall be entitled to receive (A) continuing payments of the then effective Base Salary for a period of twelve (12) months beginning on the Payment Commencement Date and payable in accordance with the Company’s payroll policies, (B) in lieu of the Targeted Incentive Bonus, a bonus payment in the amount of Forty percent (40%) of Executive’s then current Base Salary payable in one lump sum on the Payment Commencement Date and (C) the benefits set forth in Section 3(e), and (ii) acceleration of vesting of one hundred percent (100%) of the then unvested Option Shares and time-based restricted stock unit grants then held by Executive, provided, however that in each case: (x), the receipt of such payments and benefits is expressly contingent upon the Executive’s execution and delivery of a Release as described above drafted by and satisfactory to counsel for the Company, which Release must be executed and become effective within sixty (60) days following the Termination Date. The provision of payments and benefits pursuant to this Section shall be subject to the terms and conditions set forth in Exhibit A.
(d)    Definitions.  
(i)    “Change of Control” means (A) a merger or consolidation of either the Company or Pacira, Inc., a Delaware corporation (“Parent”) into another entity in which the stockholders of the Company or Parent (as applicable) do not control fifty percent (50%) or more of the total voting power of the surviving entity (other than a reincorporation merger); (B) 

the sale, transfer or other disposition of all or substantially all of the Company’s assets in liquidation or dissolution of the Company; or (C) the sale or transfer of more than fifty percent (50%) of the outstanding voting stock of the Company. In the case of each of the foregoing clauses (A), (B) and (C), a Change of Control as a result of a financing transaction of the Company or Parent shall not constitute a Change of Control for purposes of this Agreement
(ii)    “Cause” means (A) the Executive’s failure to substantially perform his duties to the Company after there has been delivered to the Executive written notice setting forth in detail the specific respects in which the Board believes that the Executive has not substantially performed his duties and, if the Company reasonably considers the situation to be correctable, a demand for substantial performance and opportunity to cure, giving the Executive thirty (30) calendar days after he receives such notice to correct the situation; (B) the Executive’s having engaged in fraud, misconduct, dishonesty, gross negligence or having otherwise acted in a manner injurious to the Company or in intentional disregard for the Company’s best interests; (C) the Executive’s failure to follow reasonable and lawful instructions from the Board and the Executive’s failure to cure such failure after receiving twenty (20) days advance written notice; (D) the Executive’s material breach of the terms of this Agreement or the Employee Proprietary Information and Inventions Assignment Agreement or any other similar agreement that may be in effect from time to time; or (E) the Executive’s conviction of, or pleading guilty or nolo contendere to, any misdemeanor involving dishonesty or moral turpitude or related to the Company’s business, or any felony.  
(iii)    “Good Reason” means the occurrence of any one or more of the following events without the prior written consent of the Executive: (A) any material reduction of the then effective Base Salary other than in accordance with this Agreement or which reduction is not related to a cross-executive team salary reduction; (B) any material breach by the Company of this Agreement; or (C) a material reduction in the Executive’s responsibilities or duties, provided that in the case of clause (C), a mere reassignment following a Change of Control to a position that is substantially similar to the position held prior to the Change of Control transaction shall not constitute a material reduction in job responsibilities or duties; provided, however, that no such event or condition shall constitute Good Reason unless (x) the Executive gives the Company a written notice of termination for Good Reason not more than ninety (90) days after the initial existence of the condition, (y) the grounds for termination (if susceptible to correction) are not corrected by the Company within thirty (30) days of its receipt of such notice and (z) the Termination Date occurs within one (1) year following the Company’s receipt of such notice. 
(e)    Benefits Continuation.  If the Executive’s employment is terminated pursuant to Section 3(b) or Section 3(c) and provided that the Executive is eligible for and elects to continue receiving group health and dental insurance pursuant to the federal “COBRA” law, 29 U.S.C. § 1161 et seq., the Company will, for a twelve (12) month period following the Payment Commencement Date (the “Benefits Continuation Period”), continue to pay the share of the premium for such coverage that is paid by the Company for active and similarly-situated employees who receive the same type of coverage.  The remaining balance of any premium costs shall be paid by the Executive on a monthly basis for as long as, and to the extent that, the Executive remains eligible for COBRA continuation.  Notwithstanding the above, in the event the Executive becomes eligible for health insurance benefits from a new employer during the Benefits Continuation Period, the Company’s obligations under this Section 3(e) shall immediately cease and the Executive shall not be entitled to any additional monthly premium payments for health insurance coverage.  Similarly, in the event the Executive becomes eligible for dental insurance benefits from a new employer during the Benefits Continuation Period, the Company’s obligations under this Section 3(e) shall immediately cease and the Executive shall not be entitled to any additional monthly premium payments for dental insurance.  The Executive hereby represents that he will notify the Company in writing within three (3) days of becoming eligible for health or dental insurance benefits from a new employer during the Benefits Continuation Period
(f)    Death.  This Agreement shall automatically terminate upon the death of the Executive and all monetary obligations of Company under Section 2 of this Agreement shall be prorated to the date of death and paid to the Executive’s estate.  
(g)    Disability.  The Company may terminate the Executive’s employment if the Executive is unable to perform any of the duties required under this Agreement for a period of three (3) consecutive months due to a “Total and Permanent Disability”. The term “Total and Permanent Disability” shall mean the existence of a permanent physical or mental illness or injury, which renders the Executive incapable of performing any material obligations or terms of this Agreement. Any dispute regarding the existence of a Total and Permanent Disability shall be resolved by a panel of three (3) physicians, one selected by Company, one selected by the Executive, and the third selected by the other two physicians. A termination of employment pursuant to this Section 3(f) shall constitute a termination for Cause.
4.    At-Will Employment.  The Executive will be an “at-will” employee of the Company, which means the employment relationship can be terminated by either the Executive or the Company for any reason, at any time, with or without prior notice and with or without cause. The Company makes no promise that the Executive’s employment will continue for any particular period of time, nor is there any promise that it will be terminated only under particular circumstances. No raise or bonus, if any, shall alter the Executive’s status as an “at-will” employee or create any implied contract of employment. Discussion of 

possible or potential benefits in future years is not an express or implied promise of continued employment. No manager, supervisor or officer of the Company has the authority to change the Executive’s status as an “at-will” employee. The “at-will” nature of the employment relationship with the Executive can only be altered by a written resolution approved by the Board.
5.    Non-Solicitation.
(a)    Non-Solicit.  The Executive agrees that during the term of the Executive’s employment with the Company, and for a period of twelve (12) months immediately following the termination of the Executive’s employment with the Company for any reason, whether with or without Cause or Good Reason, the Executive shall not either directly or indirectly solicit, induce, recruit or encourage any of the Company’s or its affiliates’ employees or consultants to terminate such employee’s or consultant’s relationship with the Company or its affiliates, or attempt to solicit, induce, recruit, encourage or take away employees or consultants of the Company or any of its affiliates, either for the Executive or for any other person or entity. Further, during the Executive’s employment with the Company or any of its affiliates and at any time following termination of the Executive’s employment with the Company or any of its affiliates for any reason, with or without Cause or Good Reason, the Executive shall not use any confidential information of the Company or any of its affiliates to attempt to negatively influence any of the Company’s or any of its affiliates’ clients or customers from purchasing Company products or services or to solicit or influence or attempt to influence any client, customer or other person either directly or indirectly, to direct such person’s or entity’s purchase of products and/or services to any person, firm, corporation, institution or other entity in competition with the business of the Company or any of its affiliates.
(b)    Specific Performance.  In the event of the breach or threatened breach by the Executive of this Section 5, the Company, in addition to all other remedies available to it at law or in equity, will be entitled to seek injunctive relief and/or specific performance to enforce this Section 5.
6.    Director and Officer Liability Insurance; Indemnification.  During the term of the Executive’s employment hereunder, the Executive shall be entitled to the same indemnification and director and officer liability insurance as the Company and its affiliates maintain for other corporate officers.
7.      Proprietary Information and Inventions Assignment Agreement.  The Executive has executed and delivered the Company’s standard Employee Proprietary Information and Inventions Assignment Agreement or similar agreement and the Executive represents and warrants that the Executive shall continue to be bound and abide by such Employee Proprietary Information and Inventions Assignment Agreement or similar agreement.
8.    Attention to Duties; Conflict of Interest.  While employed by the Company, the Executive shall devote the Executive’s full business time, energy and abilities exclusively to the business and interests of the Company, and shall perform all duties and services in a faithful and diligent manner and to the best of the Executive’s abilities. The Executive shall not, without the Company’s prior written consent, render to others services of any kind for compensation, or engage in any other business activity that would materially interfere with the performance of the Executive’s duties under this Agreement. The Executive represents that the Executive has no other outstanding commitments inconsistent with any of the terms of this Agreement or the services to be rendered to the Company. While employed by the Company, the Executive shall not, directly or indirectly, whether as a partner, employee, creditor, shareholder, or otherwise, promote, participate or engage in any activity or other business competitive with the Company’s business. The Executive shall not invest in any company or business which competes in any manner with the Company, except those companies whose securities are listed on reputable securities exchanges in the United States or European Union. 
9.    Miscellaneous.
(a)    Severability.  If any provision of this Agreement shall be found by any arbitrator or court of competent jurisdiction to be invalid or unenforceable, then the parties hereby waive such provision to the extent that it is found to be invalid or unenforceable and to the extent that to do so would not deprive one of the parties of the substantial benefit of its bargain. Such provision shall, to the extent allowable by law and the preceding sentence, be modified by such arbitrator or court so that it becomes enforceable and, as modified, shall be enforced as any other provision hereof, all the other provisions continuing in full force and effect.
(b)    No Waiver.  The failure by either party at any time to require performance or compliance by the other of any of its obligations or agreements shall in no way affect the right to require such performance or compliance at any time thereafter. The waiver by either party of a breach of any provision hereof shall not be taken or held to be a waiver of any preceding or succeeding breach of such provision or as a waiver of the provision itself. No waiver of any kind shall be effective or binding, unless it is in writing and is signed by the party against whom such waiver is sought to be enforced.

(c)    Assignment.  This Agreement and all rights hereunder are personal to the Executive and may not be transferred or assigned by the Executive at any time. The Company may assign its rights, together with its obligations hereunder, to any parent, subsidiary, affiliate or successor, or in connection with any sale, transfer or other disposition of all or substantially all of its business and assets; provided, however, that any such assignee assumes the Company’s obligations hereunder.
(d)    Withholding.  All sums payable to the Executive hereunder shall be reduced by all federal, state, local and other withholding and similar taxes and payments required by applicable law.
(e)    Entire Agreement.  This Agreement, including the agreements referred to herein (which are deemed incorporated by reference herein) constitute the entire and only agreement and understanding between the parties governing the terms and conditions of employment of the Executive with the Company and this Agreement supersedes and cancels any and all previous contracts, arrangements or understandings with governing the terms and conditions of the Executive’s employment by the Company. In the event of any conflict between the terms of any other agreement between the Executive and the Company entered into prior to the Effective Date, the terms of this Agreement shall control.
(f)    Amendment.  This Agreement may be amended, modified, superseded, cancelled, renewed or extended only by an agreement in writing executed by both parties hereto.
(g)     Headings.  The headings contained in this Agreement are for reference purposes only and shall in no way affect the meaning or interpretation of this Agreement. In this Agreement, the singular includes the plural, the plural included the singular, the masculine gender includes both male and female referents, and the word “or” is used in the inclusive sense.
(h)    Notices.  Any notices provided hereunder must be in writing and shall be deemed effective upon the earlier of personal delivery (including, personal delivery by facsimile transmission or the third day after mailing by first class mail) to the Company at its primary office location and to the Executive at his address as listed on the Company payroll (which address may be changed by written notice).
(i)    Counterparts.  This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original but all of which, taken together, constitute one and the same agreement.
(j)     Governing Law, Forum Selection, Jury Waiver.  This Agreement and the rights and obligations of the parties hereto shall be construed in accordance with the laws of the State of California without giving effect to the principles of conflict of laws. Any action, suit or other legal proceeding that is commenced to resolve any matter arising under or relating to any provision of this Agreement shall be commenced only in a court of the State of New Jersey (or, if appropriate, a federal court located within Southern District of Jersey), and the Company and the Executive each consents to the jurisdiction of such a court.  Both the Company and the Executive expressly waive any right that any party either has or may have to a jury trial of any dispute arising out of or in any way related to the Executive’s employment with or termination from the Company.

[Remainder of Page Intentionally Left Blank]

IN WITNESS WHEREOF, the Company and the Executive have executed this Executive Employment Agreement as of the date first above written.

PACIRA PHARMACEUTICALS, INC.:

By: /s/ Richard Kahr
Richard Kahr
VP, Human Resources
    
EXECUTIVE:
/s/ Scott Braunstein, MD
Scott Braunstein, MD

EXHIBIT A
Payments Subject to Section 409A
1.     Subject to this Exhibit A, any severance payments and benefits that may be due under the Agreement shall begin only upon the date of the Executive’s “separation from service” (determined as set forth below) which occurs on or after the termination of the Executive’s employment. The following rules shall apply with respect to distribution of the severance payments and benefits, if any, to be provided to the Executive under the Agreement, as applicable:
(a)    It is intended that each installment of the severance payments and benefits under the Agreement provided under shall be treated as a separate “payment” for purposes of Section 409A. Neither the Company nor the Executive shall have the right to accelerate or defer the delivery of any such payments or benefits except to the extent specifically permitted or required by Section 409A.
(b)    If, as of the date of the Executive’s “separation from service” from the Company, the Executive is not a “specified employee” (within the meaning of Section 409A), then each installment of the severance payments or benefits shall be made on the dates and terms set forth in the Agreement.
(c)    If, as of the date of the Executive’s “separation from service” from the Company, the Executive is a “specified employee” (within the meaning of Section 409A), then:
(i)    Each installment of the severance payments and benefits due under the Agreement that, in accordance with the dates and terms set forth herein, will in all circumstances, regardless of when the Executive’s separation from service occurs, be paid within the short-term deferral period (as defined under Section 409A) shall be treated as a short-term deferral within the meaning of Treasury Regulation Section 1.409A-1(b)(4) to the maximum extent permissible under Section 409A and shall be paid at the time set forth in the Agreement; and
(ii)    Each installment of the severance payments and benefits due under the Agreement that is not described in this Exhibit A, Section 1(c)(i) and that would, absent this subsection, be paid within the six-month period following the Executive’s “separation from service” from the Company shall not be paid until the date that is six months and one day after such separation from service (or, if earlier, the Executive’s death), with any such installments that are required to be delayed being accumulated during the six-month period and paid in a lump sum on the date that is six months and one day following the Executive’s separation from service and any subsequent installments, if any, being paid in accordance with the dates and terms set forth herein; provided, however, that the preceding provisions of this sentence shall not apply to any installment of payments and benefits if and to the maximum extent that that such installment is deemed to be paid under a separation pay plan that does not provide for a deferral of compensation by reason of the application of Treasury Regulation 1.409A-1(b)(9)(iii) (relating to separation pay upon an involuntary separation from service). Any installments that qualify for the exception under Treasury Regulation Section 1.409A-1(b)(9)(iii) must be paid no later than the last day of the Executive’s second taxable year following the taxable year in which the separation from service occurs.
2.    The determination of whether and when the Executive’s separation from service from the Company has occurred shall be made and in a manner consistent with, and based on the presumptions set forth in, Treasury Regulation Section 1.409A-1(h).  Solely for purposes of this Exhibit A, Section 2, “Company” shall include all persons with whom the Company would be considered a single employer under Section 414(b) and 414(c) of the Code.
3.    The Company makes no representation or warranty and shall have no liability to the Executive or to any other person if any of the provisions of the Agreement (including this Exhibit) are determined to constitute deferred compensation subject to Section 409A but that do not satisfy an exemption from, or the conditions of, that section.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00257-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00257-of-00352.parquet"}]]